SAWABE Michi 澤部倫

… Alternative Names

Sawabe Michi 澤部倫

Less

Researcher Number	30790711
Other IDs
Affiliation (Current)	2025: 名古屋市立大学, 医薬学総合研究院(医学), 研究員
Affiliation (based on the past Project Information) *help	2025: 名古屋市立大学, 医薬学総合研究院(医学), 研究員 2020 – 2023: 愛知県がんセンター(研究所), 腫瘍免疫制御TR分野, 研究員
Review Section/Research Field	Principal Investigator Basic Section 56050:Otorhinolaryngology-related Except Principal Investigator Basic Section 56050:Otorhinolaryngology-related / Basic Section 58030:Hygiene and public health-related: excluding laboratory approach
Keywords	Principal Investigator 唾液腺導管癌 / 腺様嚢胞癌 / 抗体薬物複合体 / 葉酸受容体 / 唾液腺癌 / バイオマーカー / 頭頚部癌 / 抗腫瘍免疫 / ５－FU / 葉酸摂取 / 腫瘍内細菌叢 / 頭頸部がん / 頭頸部癌 … More Except Principal Investigator … More がん抗原 / バイオマーカー / 好酸球 / 免疫チェックポイント阻害薬 / 頭頸部癌 / 遺伝環境交互作用 / 予後予測モデル / ヒト乳頭種ウイルス / 予後 / 唾液腺がん / 生活習慣 / HPV / 鼻副鼻腔がん / 中咽頭がん / 頭頸部がん Less

難治性唾液腺がんに対する葉酸受容体αを標的とした新規治療法の開発Principal Investigator
- Principal Investigator
  
  澤部倫
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Nagoya City University
簡易モニタリングのための好酸球を用いた頭頸部がん免疫治療バイオマーカーの開発
- Principal Investigator
  
  西川大輔
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Aichi Cancer Center Research Institute
The impact of life style factor on survival in patients with head and neck cancer
- Principal Investigator
  
  Kawakita Daisuke
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58030:Hygiene and public health-related: excluding laboratory approach
- Research Institution
  Nagoya City University
Development of immune biomarkers by turmoral microbiome in head and neck cancerPrincipal Investigator
- Principal Investigator
  
  Sawabe Michi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Aichi Cancer Center Research Institute

All 2021 2020

All Journal Article

[Journal Article] Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma2021
- Author(s)
  Motai Risa、Sawabe Michi、Kadowaki Shigenori、Sasaki Eiichi、Nishikawa Daisuke、Suzuki Hidenori、Beppu Shintaro、Terada Hoshino、Hanai Nobuhiro
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: online Issue: 7 Pages: 1188-1195
- DOI
  10.1007/s10147-021-01907-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18331, KAKENHI-PROJECT-21K06940
[Journal Article] Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid2021
- Author(s)
  Iwaki Sho、Kawakita Daisuke、Sawabe Michi、Matoba Takuma、Takano Gaku、Oguri Keisuke、Murashima Akihiro、Minohara Kiyoshi、Tanaka Nobukazu、Tsuge Hiroshi、Imaizumi Sae、Matsumura Ayano、Masaki Ayako、Murase Takayuki、Ogawa Masaki、Iwasaki Shinichi
- Journal Title
  
  Auris Nasus Larynx
  
  Volume: 3 Issue: 6 Pages: 00190-5
- DOI
  10.1016/j.anl.2021.06.005
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K18779, KAKENHI-PROJECT-20K10508, KAKENHI-PROJECT-19KK0202
[Journal Article] Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients.2020
- Author(s)
  Matsuki T, Okamoto I, Fushimi C, Sawabe M, Kawakita D, Sato H, Tsukahara K, Kondo T, Okada T, Tada Y, Miura K, Omura G, Yamashita T
- Journal Title
  
  Cancer Med.
  
  Volume: 9 Issue: 14 Pages: 5015-5024
- DOI
  10.1002/cam4.3124
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09339, KAKENHI-PROJECT-20K07597, KAKENHI-PROJECT-20K10508
[Journal Article] Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab2020
- Author(s)
  Nishikawa Daisuke、Suzuki Hidenori、Beppu Shintaro、Terada Hoshino、Sawabe Michi、Kadowaki Shigenori、Sone Michihiko、Hanai Nobuhiro
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 1 Pages: 339-346
- DOI
  10.1111/cas.14706
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K18331
[Journal Article] Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients.2020
- Author(s)
  Matsuki T, Okamoto I, Fushimi C, Takahashi H, Okada T, Kondo T, Sato H, Ito T, Tokashiki K, Tsukahara K, Hanyu K, Masubuchi T, Tada Y, Miura K, Omura G, Sawabe M, Kawakita D, Yamashita T
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 11 Pages: 3427-3427
- DOI
  10.3390/cancers12113427
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09339, KAKENHI-PROJECT-20K07597, KAKENHI-PROJECT-20K10508, KAKENHI-PROJECT-20K18331

1. Kawakita Daisuke (70584506)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 松尾恵太郎 (80393122)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 稲垣宏 (30232507)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 多田雄一郎 (70292430)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 西川大輔 (30750731)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 花井信広 (80381797)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 松下博和 (80597782)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 二見淳一郎 (00420498)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 小村豪

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. 的場拓磨

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

SAWABE Michi 澤部 倫

Sawabe Michi 澤部 倫

Research Projects

Research Products

Co-Researchers

難治性唾液腺がんに対する葉酸受容体αを標的とした新規治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

簡易モニタリングのための好酸球を用いた頭頸部がん免疫治療バイオマーカーの開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The impact of life style factor on survival in patients with head and neck cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of immune biomarkers by turmoral microbiome in head and neck cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients.2020

Author(s)

Journal Title

DOI

Data Source

SAWABE Michi 澤部倫

Sawabe Michi 澤部倫